Mimrylo (rusfertide acetate)

Hepcidin Mimetics Subcutaneous Vial (Ea)

Advertisement

Last reviewed · Source: First Databank (FDB) drug data

Overview

USES: This medication is used by people with polycythemia vera to treat high red blood cell counts. Rusfertide works by reducing the amount of iron available for making red blood cells.

Generic name: rusfertide acetate
Pronunciation: (RUS-fer-tide)
Drug class: Hepcidin Mimetics
Therapeutic class: Endocrine

Reference product & biosimilars

No reference, biosimilar or interchangeable associated with this drug.

Today’s intelligence on Mimrylo

Intelligence content is not available yet.

Indications

The following indications are listed for Mimrylo:

  • Polycythemia Vera

Dosing

No dosing information is available for this tab.

Drug interactions

There is no enhanced messaging for this drug.

Contraindications

There is no enhanced messaging for this drug.

Adverse reactions

There is no enhanced messaging for this drug.

Precautions

No enhanced messaging available.

ICD codes

CodeTypeDescription
Polycythemia vera
D45ICD10CMPolycythemia vera

ICD code information from First Databank (FDB).

Formulary status

Search health-plan coverage for this drug by ZIP code.

Enter a ZIP code to view available health plans.

Last reviewed · Source: First Databank (FDB) drug data